These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 36858039
1. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study. Alarcia-Lacalle A, Barrasa H, Maynar J, Canut-Blasco A, Solinís MÁ, Isla A, Rodríguez-Gascón A. Blood Purif; 2023; 52(5):464-473. PubMed ID: 36858039 [Abstract] [Full Text] [Related]
2. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL. Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [Abstract] [Full Text] [Related]
13. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study. Broeker A, Wicha SG, Dorn C, Kratzer A, Schleibinger M, Kees F, Heininger A, Kees MG, Häberle H. Crit Care; 2018 Dec 17; 22(1):341. PubMed ID: 30558639 [Abstract] [Full Text] [Related]
15. Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics. Lorenzin A, de Cal M, Perin N, Morisi N, Brendolan A, Lentini P, Zanella M, Ronco C. Blood Purif; 2024 Dec 17; 53(10):773-780. PubMed ID: 39068927 [Abstract] [Full Text] [Related]
20. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy]. Gong D, Ji D, Xie H, Xu B, Liu Y, Li L. Zhonghua Nei Ke Za Zhi; 2001 Mar 17; 40(3):183-6. PubMed ID: 11798577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]